Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Seagen Inc.
University of Chicago
Memorial Sloan Kettering Cancer Center
DEKA Biosciences
AstraZeneca
Taiho Pharmaceutical Co., Ltd.
University of Chicago
Emory University
Cantargia AB
University of Chicago
AstraZeneca
AIDS Malignancy Consortium
Oncology Institute of Southern Switzerland
Daiichi Sankyo
Genentech, Inc.
Massachusetts General Hospital
National Cancer Institute (NCI)